Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Gross Margin (2017 - 2025)

Catheter Precision has reported Gross Margin over the past 9 years, most recently at 91.6% for Q4 2025.

  • Quarterly Gross Margin fell 102.0% to 91.6% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 92.31% through Dec 2025, up 231.0% year-over-year, with the annual reading at 92.31% for FY2025, 231.0% up from the prior year.
  • Gross Margin was 91.6% for Q4 2025 at Catheter Precision, roughly flat from 92.04% in the prior quarter.
  • Over five years, Gross Margin peaked at 95.49% in Q3 2023 and troughed at 11075.0% in Q1 2021.
  • The 5-year median for Gross Margin is 90.59% (2024), against an average of 1325.52%.
  • Year-over-year, Gross Margin plummeted -1105972bps in 2021 and then skyrocketed 1011944bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 6840.0% in 2021, then skyrocketed by 82bps to 1220.0% in 2022, then soared by 108bps to 94.53% in 2023, then dropped by -2bps to 92.62% in 2024, then dropped by -1bps to 91.6% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Gross Margin are 91.6% (Q4 2025), 92.04% (Q3 2025), and 93.4% (Q2 2025).